STRATA Skin Sciences, Inc. — Director's Dealing 2018

Sep 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2018-06-15

Reporting Person: Accelmed Growth Partners, L.P. (10% Owner)
Reporting Person: Accelmed Growth Partners (GP), L.P. (10% Owner)
Reporting Person: Accelmed Growth Partners (AGP) Ltd (10% Owner)
Reporting Person: Accelmed Growth Partners Management Ltd. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-15	Common Stock, $0.001 par value per share	J	75590	$1.09	Acquired	12112627	Direct
2018-06-15	Common Stock, $0.001 par value per share	J	75590	$1.09	Acquired	12112627	Indirect
2018-06-15	Common Stock, $0.001 par value per share	J	75590	$1.09	Acquired	12112627	Indirect
2018-06-15	Common Stock, $0.001 par value per share	J	75590	$1.09	Acquired	12112627	Indirect

Footnotes

F1: 6/15/18 the reporting person (through indirect ownership) was entitled to receive 75,590 shares of the common stock pursuant to a "retained risk" provision in the Securities Purchase Agreement between the Company and Accelmed Growth Partners, L.P. dated 5/29/18 ("Purchase Agreement"). Purchase Agreement provided that the purchaser would receive additional shares of common stock in the event of certain contingent expense events, one of which was determined to have occurred on 6/15/18, resulted in the purchaser acquired additional shares. The number of shares issuable pursuant to that provision, determined on 6/15/18 pursuant to a formula set forth in the Purchase Agreement provided that, for purposes of determining the number of shares issuable, the common stock would be valued at $1.09 per share, which was the purchase price of the common stock in the Purchase Agreement.

F2: These shares are held directly by Accelmed Growth Partners, L.P. and may be deemed to be beneficially owned indirectly by (i) Accelmed Growth Partners (GP), L.P., the general partner of Accelmed Growth Partners, L.P., (ii) Accelmed Growth Partners (AGP) Limited, the general partner of Accelmed Growth Partners (GP), L.P., and (iii) Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares pursuant to a management agreement. Each of Accelmed Growth Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd. disclaims such beneficial ownership except to the extent of its pecuniary interest in the shares.